← Back to Search

Adductor Canal Nerve Block group for Postoperative Pain

N/A
Waitlist Available
Led By Jean Louis-Horn, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Scheduled for ACL reconstruction surgery with patellar autograft
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial is testing whether a continuous femoral nerve block or a continuous adductor canal block is better for pain control and quality of recovery after ACL reconstruction surgery.

Eligible Conditions
  • Postoperative Pain
  • Anterior Cruciate Ligament Injury

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are planning to have surgery to reconstruct your ACL using a piece of your own patellar tendon.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Score
Secondary outcome measures
CPM compliance
Opioid Use
Other outcome measures
Bolus dose usage
Quadriceps Circumference, percent of baseline
Quality of Recovery
+1 more

Trial Design

2Treatment groups
Active Control
Group I: Adductor Canal Nerve Block groupActive Control2 Interventions
Adductor Canal perineural catheter placement. Adductor Canal continuous perineural infusion. Ropivacaine 0.2% will be administered at a continuous rate of 5 mL/hour through a perineural catheter placed in the adductor canal. A Nimbus pump (Infutronix) will be delivering the medication.
Group II: Femoral Nerve Block groupActive Control2 Interventions
Femoral Nerve perineural catheter placement. Femoral continuous perineural infusion. Ropivacaine 0.2% will be administered at a continuous rate of 5 mL/hour through a perineural catheter placed near the femoral nerve. A Nimbus pump (Infutronix) will be delivering the medication.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,374 Previous Clinical Trials
17,332,867 Total Patients Enrolled
7 Trials studying Postoperative Pain
1,042 Patients Enrolled for Postoperative Pain
Jean Louis-Horn, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
123 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people have been recruited to participate in this research endeavor?

"Affirmative. According to clinicaltrials.gov, the study that began on June 18th 2018 is still actively seeking participants. The trial requires 50 individuals across one site and was most recently updated November 1st 2022."

Answered by AI

Are there any opportunities currently available to participate in this experiment?

"As documented on clinicaltrials.gov, this investigation is in search of participants. It was first made available to the public on June 18th 2018 and was recently revised on November 1st 2022."

Answered by AI
~9 spots leftby Mar 2025